United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 3 minute read Pharma Industry News REGENXBIO and Nippon Shinyaku collaborate on transformative gene therapies for MPS disorders In a significant move for the treatment of rare genetic diseases, REGENXBIO Inc. has entered an exclusive partnership… byPallavi MadhirajuJanuary 14, 2025